A Hybrid Model to Study Amyloid Cross-Toxicity
Author(s) -
Gabriela Henrı́quez,
Lois Méndez,
Mahesh Narayan
Publication year - 2020
Publication title -
acs chemical neuroscience
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.158
H-Index - 69
ISSN - 1948-7193
DOI - 10.1021/acschemneuro.9b00692
Subject(s) - neurodegeneration , amyloid (mycology) , protein aggregation , prion protein , biology , mechanism (biology) , neuroscience , toxicity , chemistry , disease , microbiology and biotechnology , medicine , philosophy , botany , organic chemistry , epistemology
The self-seeding mechanism characteristic of the prion-protein has also been attributed to other neurodegenerative-disease-associated proteins including amyloid beta (Aβ), tau, and α-synuclein. An interesting facet of these prion-like proteins is their ability to horizontally "spread" and recruit their soluble counterparts in adjacent neurons. However, recent findings suggest a heterotoxic potential in these "seeds" whereby one neurodegeneration-associated protein can interact with another sequentially unrelated prion-like protein and influence its aggregation and drive cross-toxic outcomes and neurodegenerative co-morbidity. Yet, direct experimental evidence for amyloid cross-talk at the vertebrate level remains indirect, lacks resolution, or introduces confounding variables. Here, we discuss the need for a novel approach to resolve amyloid cross-toxicity at the neurohistochemical and organismal levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom